The potential for renoprotection with incretin-based drugs

Keywords

IncretinMedicinePharmacologyEndocrinologyDiabetes mellitusType 2 diabetes

Affiliated Institutions

The University of Tokyo JP

Related Publications

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Vlado Perkovic , Meg Jardine , Bruce Neal +21 more

In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a med...

2019 New England Journal of Medicine 5513 citations

Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus

Jerrold M. Olefsky , Orville Kolterman , J A Scarlett

Resistance to the action of insulin can result from a variety of causes, including the formation of abnormal insulin or proinsulin molecules, the presence of circulating antagon...

1982 American Journal of Physiology-Endocr... 277 citations

Non‐alcoholic steatohepatitis: What is it, and why is it important in the Asia–Pacific region?

Geoffrey C. Farrell

Abstract Non‐alcoholic steatohepatitis (NASH), is a critical link in the chain of metabolic fatty liver disorders that spans steatosis to cryptogenic cirrhosis. It is the hepati...

2003 Journal of Gastroenterology and Hepat... 233 citations

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Melanie J. Davies , David A. D’Alessio , Judith Fradkin +7 more

The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the prior position statements, published in 2012 and 2015, on...

2018 Diabetes Care 3378 citations

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation

K. G. M. M. Alberti , Paul Zimmet

The classification of diabetes mellitus and the tests used for its diagnosis were brought into order by the National Diabetes Data Group of the USA and the second World Health O...

1998 Diabetic Medicine 15102 citations

Publication Info

Year: 2014
Type: review
Volume: 86
Issue: 4
Pages: 701-711
Citations: 123
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

The potential for renoprotection with incretin-based drugs

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

123

OpenAlex

Cite This

APA Style

                            
                                
                                    Tetsuhiro Tanaka, 
                                
                                    Yoshiki Higashijima, 
                                
                                    Takehiko Wada
                                
                                et al.
                            
                            (2014). 
                            The potential for renoprotection with incretin-based drugs. 
                            Kidney International
                            , 86
                            (4)
                            , 701-711.
                            https://doi.org/10.1038/ki.2014.236
                        

Identifiers

DOI: 10.1038/ki.2014.236